From curing cancer to reducing addictions to curtailing concussions, Indiana University researchers are tackling some of our biggest medical challenges in an effort to preserve and enhance human health.
Enhancing the health of Hoosiers and beyond
Improving Hoosier health
Alzheimer's in low-income areas
IU researchers are studying how socioeconomic exposures in mid-to-later-life affect memory decline and Alzheimer’s disease and related dementia risk.
Learn more about IU's work on Alzheimer's
Prenatal exposure to THC, CBD affects offspring response to Prozac
IU scientists have found evidence that when the developing brains of mice are exposed to THC or CBD, they impair the mice's ability as adults to respond to fluoxetine, a drug commonly used to treat anxiety and depression known by the brand name Prozac.
Learn more about the research
Cell-based therapies to prevent limb loss
The Indiana Center for Regenerative Medicine and Engineering is at the national forefront in developing treatments that help save the limbs of patients with severe peripheral arterial disease.
Learn more about IU's research on severe PAD
-
IUPUI faculty honored as 2021 Research Frontiers Trailblazers
This annual recognition honors IUPUI associate professors who have made exceptional contributions to research in their field.
-
Project to improve health equity in Indianapolis expands with funding from Lilly
The Fairbanks School of Public Health at IUPUI has received a five-year, $5 million grant to expand the Diabetes Impact Project.
-
IU Bloomington climbs US News rankings; IUPUI ranks high in innovation, service learning
Bloomington is 26th among public national universities; IUPUI ties for 21st for service learning; and the Kelley School is eighth overall.
-
Ask the Expert: COVID-19 vaccine boosters
Dr. Lana Dbeibo, one of the medical experts leading IU's response to the pandemic, answers key questions about COVID-19 vaccine boosters.
-
From IU to Amazon: Alumni startup, founded as student, grows into pilot partnership with tech giant
A startup established five years ago by a student at IU has been a named a pilot partner with Amazon Sidewalk.
-
Statewide survey measures COVID-19 vaccine intentions among parents of Indiana children
Preliminary results from a survey of parents/caregivers found that only 44.8% will be vaccinating their school-age children or already have.
-
IU Ventures makes $475,000 in renewed investments in emerging health, technology companies
Apexian is a clinical-stage biotech company led by an IU professor, and NuCurrent is a wireless technology company led by an IU alum.
-
Nearly 140,000 U.S. deaths prevented by early COVID-19 vaccinations
A new study found that COVID-19 vaccines prevented 139,393 deaths during the first five months of vaccination efforts in the U.S.
-
Sustainability through insect farming: $2.2M NSF grant funds center to address food shortages
The Center for Environmental Sustainability Through Insect Farming will explore the use of insects to address global food shortages.
-
Trustees approve 2 new degrees at Bloomington and IUPUI
The Board of Trustees has approved new degrees at the IU School of Public Health-Bloomington and IU School of Liberal Arts at IUPUI.